Conference Paper: A phase I/II study of Foretinib, an oral multikinase inhibitor targeting MET, RON, AXL, TIE-2 and VEGFR in advanced hepatocellular carcinoma (HCC)
| Title | A phase I/II study of Foretinib, an oral multikinase inhibitor targeting MET, RON, AXL, TIE-2 and VEGFR in advanced hepatocellular carcinoma (HCC) |
|---|---|
| Authors | Yau, TCC Sukeepaisarnjaroen, W Chao, Y Yen, CJ Lausoontornsiri, W Chen, PJ Sanpajit, T Lencioni, R Camp, A Kallender, H Ottesen, LH Poon, RTP |
| Issue Date | 2011 |
| Citation | Journal of Clinical Oncology, v. 29 n. Suppl, p. abstr 4082 [How to Cite?] |
| dc.contributor.author | Yau, TCC |
|---|---|
| dc.contributor.author | Sukeepaisarnjaroen, W |
| dc.contributor.author | Chao, Y |
| dc.contributor.author | Yen, CJ |
| dc.contributor.author | Lausoontornsiri, W |
| dc.contributor.author | Chen, PJ |
| dc.contributor.author | Sanpajit, T |
| dc.contributor.author | Lencioni, R |
| dc.contributor.author | Camp, A |
| dc.contributor.author | Kallender, H |
| dc.contributor.author | Ottesen, LH |
| dc.contributor.author | Poon, RTP |
| dc.date.accessioned | 2012-08-16T06:11:05Z |
| dc.date.available | 2012-08-16T06:11:05Z |
| dc.date.issued | 2011 |
| dc.identifier.citation | Journal of Clinical Oncology, v. 29 n. Suppl, p. abstr 4082 [How to Cite?] |
| dc.identifier.epage | abstr 4082 |
| dc.identifier.hkuros | 202728 |
| dc.identifier.issue | Suppl |
| dc.identifier.spage | abstr 4082 |
| dc.identifier.uri | http://hdl.handle.net/10722/160425 |
| dc.identifier.volume | 29 |
| dc.language | eng |
| dc.relation.ispartof | Journal of Clinical Oncology |
| dc.title | A phase I/II study of Foretinib, an oral multikinase inhibitor targeting MET, RON, AXL, TIE-2 and VEGFR in advanced hepatocellular carcinoma (HCC) |
| dc.type | Conference_Paper |